Latest from Sylvester Comprehensive Cancer Center

A. Craig Lockhart, MD, MHS, professor and associate director for Regional and Strategic Clinical Research Affiliations, Sylvester Comprehensive Cancer Center, University of Miami Health System, discusses dual-immunotherapy strategies in colorectal cancer (CRC).
Based on available data, treatment is not that obvious for patients with metastatic non–small cell lung cancer who are tolerating treatment well and have either a complete or partial response to therapy.
Gilberto De Lima Lopes, MD, discusses the standard of care for pembrolizumab in patients with metastatic lung cancer.
Matthew P. Schlumbrecht, MD, discusses the treatment of women with uterine leiomyosarcoma.
Matthew P. Schlumbrecht, MD, discusses remaining challenges in uterine leiomyosarcoma.
A. Craig Lockhart, MD, MHS, professor and associate director for Regional and Strategic Clinical Research Affiliations, Sylvester Comprehensive Cancer Center, University of Miami Health System, discusses investigational strategies targeting the RAS/RAF/MEK/ERK pathway in colorectal cancer (CRC).
Matthew P. Schlumbrecht, MD, discusses the role of surgical resection in uterine leiomyosarcoma.
A. Craig Lockhart, MD, MHS, discusses ongoing developments and the future of immunotherapy in colorectal cancer.
Publication Bottom Border
Border Publication
x